These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 26022686)

  • 1. Fragment virtual screening based on Bayesian categorization for discovering novel VEGFR-2 scaffolds.
    Zhang Y; Jiao Y; Xiong X; Liu H; Ran T; Xu J; Lu S; Xu A; Pan J; Qiao X; Shi Z; Lu T; Chen Y
    Mol Divers; 2015 Nov; 19(4):895-913. PubMed ID: 26022686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictions of BuChE inhibitors using support vector machine and naive Bayesian classification techniques in drug discovery.
    Fang J; Yang R; Gao L; Zhou D; Yang S; Liu AL; Du GH
    J Chem Inf Model; 2013 Nov; 53(11):3009-20. PubMed ID: 24144102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QSAR classification model for antibacterial compounds and its use in virtual screening.
    Singh N; Chaudhury S; Liu R; AbdulHameed MD; Tawa G; Wallqvist A
    J Chem Inf Model; 2012 Oct; 52(10):2559-69. PubMed ID: 23013546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virtual Screening Strategy Combined Bayesian Classification Model, Molecular Docking for Acetyl-CoA Carboxylases Inhibitors.
    Zhou WN; Zhang YM; Qiao X; Pan J; Yin LF; Zhu L; Zhao JN; Lu S; Lu T; Chen YD; Liu HC
    Curr Comput Aided Drug Des; 2019; 15(3):193-205. PubMed ID: 30411690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virtual screening and synthesis of new chemical scaffolds as VEGFR-2 kinase inhibitors.
    Elsayed MS; El-Araby ME; Serya RT; Abouzid KA
    Arzneimittelforschung; 2012 Dec; 62(12):554-60. PubMed ID: 23023518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dynamics-based discovery of novel phosphodiesterase-9A inhibitors with non-pyrazolopyrimidinone scaffolds.
    Li Z; Lu X; Feng LJ; Gu Y; Li X; Wu Y; Luo HB
    Mol Biosyst; 2015 Jan; 11(1):115-25. PubMed ID: 25328054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How diverse are diversity assessment methods? A comparative analysis and benchmarking of molecular descriptor space.
    Koutsoukas A; Paricharak S; Galloway WR; Spring DR; Ijzerman AP; Glen RC; Marcus D; Bender A
    J Chem Inf Model; 2014 Jan; 54(1):230-42. PubMed ID: 24289493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mining for bioactive scaffolds with scaffold networks: improved compound set enrichment from primary screening data.
    Varin T; Schuffenhauer A; Ertl P; Renner S
    J Chem Inf Model; 2011 Jul; 51(7):1528-38. PubMed ID: 21615076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementing relevance feedback in ligand-based virtual screening using Bayesian inference network.
    Abdo A; Salim N; Ahmed A
    J Biomol Screen; 2011 Oct; 16(9):1081-8. PubMed ID: 21862688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Bayesian Target Predictor Method based on Molecular Pairing Energies estimation.
    Oliver A; Canals V; Rosselló JL
    Sci Rep; 2017 Mar; 7():43738. PubMed ID: 28263323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of CK2 inhibitors with new scaffolds by a hybrid virtual screening approach based on Bayesian model; pharmacophore hypothesis and molecular docking.
    Di-wu L; Li LL; Wang WJ; Xie HZ; Yang J; Zhang CH; Huang Q; Zhong L; Feng S; Yang SY
    J Mol Graph Model; 2012 Jun; 36():42-7. PubMed ID: 22516037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fragment-based approach to drug lead discovery: overview and advances in various techniques.
    Fattori D; Squarcia A; Bartoli S
    Drugs R D; 2008; 9(4):217-27. PubMed ID: 18588353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How Size Matters: Diversity for Fragment Library Design.
    Shi Y; von Itzstein M
    Molecules; 2019 Aug; 24(15):. PubMed ID: 31387220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study on the use of docking and Bayesian categorization to predict ligand binding to nicotinic acetylcholine receptors (nAChRs) subtypes.
    Kombo DC; Bencherif M
    J Chem Inf Model; 2013 Dec; 53(12):3212-22. PubMed ID: 24328365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic generation of chemical structures for rational drug design based on QSAR models.
    Funatsu K; Miyao T; Arakawa M
    Curr Comput Aided Drug Des; 2011 Mar; 7(1):1-9. PubMed ID: 20550510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Open Source Tools and Resources in Virtual Screening for Drug Discovery.
    Karthikeyan M; Vyas R
    Comb Chem High Throughput Screen; 2015; 18(6):528-43. PubMed ID: 26138575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Scaffold FingerPrint (SFP): applications in scaffold hopping and scaffold-based selection of diverse compounds.
    Rabal O; Amr FI; Oyarzabal J
    J Chem Inf Model; 2015 Jan; 55(1):1-18. PubMed ID: 25558803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collection and preparation of molecular databases for virtual screening.
    Saxena AK; Prathipati P
    SAR QSAR Environ Res; 2006 Aug; 17(4):371-92. PubMed ID: 16920660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New fragment weighting scheme for the Bayesian inference network in ligand-based virtual screening.
    Abdo A; Salim N
    J Chem Inf Model; 2011 Jan; 51(1):25-32. PubMed ID: 21155550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple pharmacophore models combined with molecular docking: a reliable way for efficiently identifying novel PDE4 inhibitors with high structural diversity.
    Chen Z; Tian G; Wang Z; Jiang H; Shen J; Zhu W
    J Chem Inf Model; 2010 Apr; 50(4):615-25. PubMed ID: 20353193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.